Memorial Sloan Kettering Cancer Center
- Country
- ๐บ๐ธUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Chronic Myelogenous Leukemia
- Conditions
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00005618
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Vaccine Therapy in Treating Patients With Recurrent Soft Tissue Sarcoma
- Conditions
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2013-06-19
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00005628
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin
- Conditions
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2013-06-05
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00006043
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum
- Conditions
- First Posted Date
- 2004-04-02
- Last Posted Date
- 2011-04-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00005860
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Cisplatin Plus Irinotecan in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer
- Conditions
- First Posted Date
- 2004-03-30
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 35
- Registration Number
- NCT00003345
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Taurolidine in Treating Patients With Recurrent or Progressive Glioma
- Conditions
- First Posted Date
- 2004-03-19
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00022360
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
ZD 1839 in Treating Patients With Metastatic Kidney Cancer
- Conditions
- First Posted Date
- 2004-03-17
- Last Posted Date
- 2013-06-24
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00012337
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
PS-341 in Treating Patients With Hematologic Cancer
- Conditions
- First Posted Date
- 2004-03-17
- Last Posted Date
- 2013-06-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00006098
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
Cetuximab in Treating Patients With Stage IV Colorectal Cancer
- Conditions
- First Posted Date
- 2004-03-17
- Last Posted Date
- 2009-12-04
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00020930
- Locations
- ๐บ๐ธ
Memorial Sloan-Kettering Cancer Center, New York, New York, United States
ILX23-7553 in Treating Patients With Solid Tumors That Have Not Responded to Previous Therapy
- Conditions
- First Posted Date
- 2004-03-16
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Registration Number
- NCT00004926
- Locations
- ๐บ๐ธ
New Jersey Medical School, Newark, New Jersey, United States
๐บ๐ธMemorial Sloan-Kettering Cancer Center, New York, New York, United States